Breaking down barriers to patient access; What is needed from stakeholders to bring down barriers to market access in emerging markets
- At: Glasgow (Scotland) (2018)
- Type: Presentation
- By: SOLARIN, Sola (Savanté Consulting, Nigeria)
- Co-author(s): Sola Solarin
Informed estimate for access to medicines globally is 67%. When disaggregated , emerging market have an average of 50%.
A number of factors have been identified as responsible for poor access to medicines in emerging markets. They include poor infrastructure, sub-optimal supply chain, policy choices, patents, access to data among others.
Differen.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.